Spruce Biosciences Inc
OTC:SPRB
Spruce Biosciences Inc
OTC:SPRB
Price:
80.8501
USD
-3.75%
Market Closed
Market Cap:
$110.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Spruce Biosciences Inc
OTC:SPRB
|
US |
|
U
|
US Bancorp
XETRA:UB5
|
US |
|
C
|
Ceconomy AG
OTC:MTAGF
|
DE |
|
Essity AB (publ)
STO:ESSITY B
|
SE |
|
Steel Dynamics Inc
NASDAQ:STLD
|
US |
|
Hoya Corp
F:HYB
|
JP |
Income Statement
Earnings Waterfall
Spruce Biosciences Inc
Spruce Biosciences Inc
Income Statement
Spruce Biosciences Inc
Spruce Biosciences Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
4
+111%
|
7
+74%
|
10
+40%
|
10
+0%
|
10
-6%
|
7
-26%
|
5
-31%
|
3
-41%
|
1
-55%
|
1
-46%
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(39)
|
(41)
|
(42)
|
(44)
|
(44)
|
(44)
|
(47)
|
(51)
|
(55)
|
(60)
|
(62)
|
(62)
|
(57)
|
(50)
|
(61)
|
(61)
|
(52)
|
(50)
|
(37)
|
|
| Selling, General & Administrative |
(10)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(15)
|
(14)
|
(14)
|
(13)
|
(17)
|
|
| R&D |
(29)
|
(30)
|
(31)
|
(33)
|
(32)
|
(33)
|
(35)
|
(38)
|
(42)
|
(47)
|
(49)
|
(48)
|
(43)
|
(36)
|
(46)
|
(47)
|
(38)
|
(37)
|
(20)
|
|
| Operating Income |
(39)
N/A
|
(41)
-5%
|
(42)
-2%
|
(44)
-5%
|
(44)
0%
|
(44)
0%
|
(47)
-7%
|
(49)
-3%
|
(51)
-4%
|
(53)
-4%
|
(52)
+2%
|
(51)
+1%
|
(47)
+8%
|
(43)
+9%
|
(56)
-30%
|
(58)
-3%
|
(51)
+13%
|
(49)
+2%
|
(37)
+26%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
4
|
5
|
5
|
5
|
4
|
3
|
3
|
3
|
2
|
(2)
|
|
| Pre-Tax Income |
(40)
N/A
|
(41)
-5%
|
(42)
-2%
|
(44)
-4%
|
(44)
0%
|
(44)
+0%
|
(46)
-4%
|
(47)
-2%
|
(48)
-2%
|
(49)
-2%
|
(48)
+2%
|
(47)
+2%
|
(43)
+8%
|
(39)
+9%
|
(53)
-35%
|
(55)
-5%
|
(48)
+13%
|
(48)
+1%
|
(39)
+19%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(40)
|
(41)
|
(42)
|
(44)
|
(44)
|
(44)
|
(46)
|
(47)
|
(48)
|
(49)
|
(48)
|
(47)
|
(43)
|
(39)
|
(53)
|
(55)
|
(48)
|
(48)
|
(39)
|
|
| Net Income |
(40)
N/A
|
(41)
-5%
|
(42)
-2%
|
(44)
-4%
|
(44)
0%
|
(44)
+0%
|
(46)
-4%
|
(47)
-2%
|
(48)
-2%
|
(49)
-2%
|
(48)
+2%
|
(47)
+2%
|
(43)
+8%
|
(39)
+9%
|
(53)
-35%
|
(55)
-5%
|
(48)
+13%
|
(48)
+1%
|
(39)
+19%
|
|
| EPS (Diluted) |
-127.3
N/A
|
-133.07
-5%
|
-135.8
-2%
|
-141.01
-4%
|
-141.32
0%
|
-140.76
+0%
|
-147.24
-5%
|
-110.99
+25%
|
-89.08
+20%
|
-90.47
-2%
|
-93.35
-3%
|
-85.33
+9%
|
-78.55
+8%
|
-71.61
+9%
|
-96.42
-35%
|
-94.66
+2%
|
-81.77
+14%
|
-85.03
-4%
|
-50.83
+40%
|
|
Switch to:
Switch to:
See Also
Other Spruce Biosciences Inc listings:
Discover More
